Navigation Links
ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin,Conjugate Data Presented at American Diabetes Association Annual,Meeting

ity of Exendin-4 is somewhat limited by its relatively short half-life in plasma. Developed with ConjuChem's proprietary PC-DAC(TM) technology, PC-DAC(TM):Exendin-4 is a modified Exendin-4 analogue that is covalently bound to recombinant human albumin (Recombumin(R), provided by Novozymes Delta Limited). Data from Phase I/II clinical studies have demonstrated that the preformed albumin-peptide conjugate has a much longer half-life than the peptide alone. The product is a highly soluble liquid formulation that is injectable in a small volume with a small gauge needle.

About ConjuChem

ConjuChem, developer of next generation medicines from therapeutic peptides, is creating long-acting compounds based on bioconjugation platform technologies. When applied to peptides, the Company's systemic DAC(TM) and PC-DAC(TM) Technologies enable the creation of new drugs with significantly enhanced therapeutic properties as compared to the original peptide. Detailed descriptions of the Company can be viewed on the Company's website http://www.conjuchem.com.

-30-

/For further information: Lennie Ryer, CA, Vice President Finance, CFO, ConjuChem Biotechnologies Inc., (514) 844-5558 ext 224, mpolonsky@equicomgroup.com


'"/>




Page: 1 2 3

Related medicine technology :

1. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
2. Gemin X Biotechnologies Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
(Date:8/19/2008)...n., Aug. 19 /- VION,PHARMAC... that it had,entered into an agreement with the Du... Oncology (the "HOVON") to conduct a clinical tria... standard remission-induction,therapy in patients ...nous,leukemia (AML) and high-risk myelodysplasia (...
(Date:8/18/2008)...8 /PRNewswire-USNewswire/ -- Boston University and... Center for Human Genetics, Inc.,("CHG") and Direc...versity,announced that CHG will no longer offer t...ena Diagnostics, Inc., These patented tests inclu...d to A1555G or Connexin 26 mutations, developmenta...
(Date:8/18/2008)... with Strong Clinical Research Relationships and P...ons to Lead Commercialization, SANTA CLARA, Calif...c.,(OTC Bulletin Board: NWCI) a cardiac diagnosti...nt W. Renz has joined NewCardio as its president. ...ion effort, to include,business development, clien...
(Date:8/15/2008)...Aug. 15 /- Globus Medical, Inc., the ... in the world, today announced,that the first FLEX...der an,Investigational Device Exemption ("IDE") re...and Dr. Rhett Murray., The FLEXUS(TM) Spacer is p...us processes with minimal disruption to the surrou...
Breaking Medicine Technology:Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 1Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 2Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 3Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 4Principle of Recursive Genome Function Supersedes Dogmas 3B By Andras Pellionisz Online Ahead of Print 3B 28Scientific Visionary Vindicated 29 6587 5Tips on how to build a better home for biological parts 4079 1Tips on how to build a better home for biological parts 4079 2Tips on how to build a better home for biological parts 4079 3Concentric Named to List of Top 60 Healthcare Agencies in U S 24118 1Concentric Named to List of Top 60 Healthcare Agencies in U S 24118 2MDCT virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers 24114 1
...e than half of infertile couples willing to,donate...Md., June 20, 2007 /PRNewswire/ -- RESOLVE: The,Na...g statement,today, in anticipation of President Bu... current limitations on stem cell,research: , "Pre...fe-saving,gift the infertility community is willin...
...USINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceutica...cal,data highlighting the ability of Glufast(R) (m...ation therapy with metformin, to,manage glucose su...ed in the Abstract Book for the American Diabetes,...cago, Illinois.,Glufast is an insulin secretagogue...
Other Medicine Technology:Infertile Voice Supports Stem Cell Research: RESOLVE Calls for,Patient Options in Using Frozen Embryos 2Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 2Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 3Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 4Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes 5
(Date:8/20/2008)... CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ -- ...reported preliminary income from,continuing operat... $27.5,million, or $0.76 per diluted share, includ...r diluted share, related to provisions for store,c...a 6.8 percent increase,compared with income from c...
(Date:8/20/2008)...IELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Chan...lness Promotion will give thousands of,Detroit met...LTHY LIVING,FOR KIDS" program. This year the progr...m. to 5 p.m. at the Charles H. Wright Museum of Af...7, "Healthy Living for Kids",has provided free imm...
(Date:8/20/2008)...N and OTTAWA, Aug. 20 /PRNewswire-FirstCall/ -- iN...nd information portal, announced,today the third w...g a free,Nintendo Wii and Wii Fit system. The Winn...n, Michigan. iNutrition sweepstakes winner Ron Mil...excited." He then told his,son who responded with,...
(Date:8/20/2008)...PRINGS, Pa., Aug. 20 /PRNewswire-USNewswire/ -- Go... agricultural industry is struggling,with high fue...ng the need,to secure the state,s energy independe...g adults., Nearly 900 guests gathered to hear the...ay Luncheon at Ag Progress Days, Pennsylvania,s,la...
Breaking Medicine News(10 mins):Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Weight Loss and Fitness Information Site iNutrition.com Gives Away Third Nintendo Wii and Wii Fit 2Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2
...lips who was on his way to becoming a lawyer says ...// “The top step had ice, and I went straight over...urs, and when they found me, I had blood coming ou... recollection for two and a half years after that ...
... their risk of birth defects. Now, new research sh...e.// Researchers say about 31,000 stroke-related d...s may have been prevented each year since fortific...s homocysteine levels. People with higher homocyst...
...esearchers say the estrogen pills do not reduce th...ed risk of stroke.// Researchers say their result...or decrease the risk of heart disease as combinati...trogen also does not appear to affect a woman’s ri...
...could help fight another. Researchers say the litt...G , may hold a key to helping researchers devise n...results from the Multicenter Acquired Immunodefici...estigators followed a large group of HIV-infected ...
Other Medicine News:
Inquire
The Perfect Single basic Vac Manifold is used to process a single 96-well plate; processing time is approximately 30 minutes.
The Perfect Single Vac Manifold is available to process one 96-well plate in 30 minutes; the manifold is designed with an "open/closed" switch and a vacuum regulator with gauge for easy operation. co
...from Caliper provide an automated alternative to K...low-Down Evaporators. For over ten years TurboVap ...laim with over 4,000 units in use around the world... ...
Medicine Products: